|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Audentes Therapeutics, Inc. (BOLD) |
|
|
$59.97 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
45,860,000 |
| Market
Cap: |
2.75(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$59.97 - $59.97 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Soloway Thomas P |
Executive Vice President, CFO |
• – – |
2019-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
23,333 |
23,333 |
|
- |
|
| Patterson Matthew R |
Chief Executive Officer |
• • – |
2019-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
63,700 |
118,700 |
|
- |
|
| Prasad Suyash |
Senior VP & Chief Med Officer |
• – – |
2019-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
17,500 |
18,236 |
|
- |
|
| Holles Natalie C. |
President and COO |
• – – |
2019-01-24 |
4 |
OE |
$2.76 |
$22,949 |
D/D |
8,300 |
33,390 |
|
- |
|
| Lange Louis G |
Director |
– • – |
2018-12-24 |
4 |
AS |
$18.50 |
$222,365 |
I/I |
(12,000) |
32,343 |
|
- |
|
| Lange Louis G |
Director |
– • – |
2018-12-24 |
4 |
AS |
$18.67 |
$373,434 |
D/D |
(20,000) |
325,799 |
|
- |
|
| Patterson Matthew R |
Chief Executive Officer |
• • – |
2018-12-06 |
4 |
OE |
$0.78 |
$31,200 |
D/D |
40,000 |
55,000 |
|
- |
|
| Prasad Suyash |
Senior VP & Chief Med Officer |
• – – |
2018-11-15 |
4 |
A |
$19.64 |
$14,451 |
D/D |
736 |
736 |
|
- |
|
| Lange Louis G |
Director |
– • – |
2018-11-15 |
4 |
S |
$22.49 |
$89,960 |
I/I |
(4,000) |
3,555 |
|
- |
|
| Lange Louis G |
Director |
– • – |
2018-11-15 |
4 |
S |
$22.49 |
$449,800 |
D/D |
(20,000) |
345,799 |
|
- |
|
| Newman Mary |
SVP, Regulatory Affairs |
• – – |
2018-11-15 |
4 |
A |
$19.64 |
$12,959 |
D/D |
660 |
660 |
|
- |
|
| Prasad Suyash |
Senior VP & Chief Med Officer |
• – – |
2018-10-01 |
4 |
AS |
$35.60 |
$368,788 |
D/D |
(10,000) |
0 |
|
- |
|
| Prasad Suyash |
Senior VP & Chief Med Officer |
• – – |
2018-10-01 |
4 |
OE |
$0.79 |
$7,900 |
D/D |
10,000 |
4,699 |
|
- |
|
| Patterson Matthew R |
Chief Executive Officer |
• • – |
2018-10-01 |
4 |
AS |
$37.70 |
$801,372 |
D/D |
(21,000) |
15,000 |
|
- |
|
| Patterson Matthew R |
Chief Executive Officer |
• • – |
2018-10-01 |
4 |
OE |
$0.78 |
$16,380 |
D/D |
21,000 |
23,078 |
|
- |
|
| Gray John T. |
SVP, Chief Scientific Officer |
• – – |
2018-09-28 |
4 |
AS |
$40.00 |
$3,480 |
D/D |
(87) |
0 |
|
- |
|
| Gray John T. |
SVP, Chief Scientific Officer |
• – – |
2018-09-28 |
4 |
OE |
$1.05 |
$91 |
D/D |
87 |
87 |
|
- |
|
| Lange Louis G |
Director |
– • – |
2018-09-24 |
4 |
AS |
$37.25 |
$486,319 |
I/I |
(13,000) |
42,343 |
|
- |
|
| Lange Louis G |
Director |
– • – |
2018-09-24 |
4 |
AS |
$37.35 |
$747,061 |
D/D |
(20,000) |
365,799 |
|
- |
|
| Patterson Matthew R |
Chief Executive Officer |
• • – |
2018-09-24 |
4 |
OE |
$0.78 |
$11,700 |
D/D |
15,000 |
15,000 |
|
- |
|
| Patterson Matthew R |
Chief Executive Officer |
• • – |
2018-09-18 |
4 |
AS |
$40.00 |
$518,080 |
D/D |
(12,952) |
0 |
|
- |
|
| Patterson Matthew R |
Chief Executive Officer |
• • – |
2018-09-18 |
4 |
OE |
$2.19 |
$28,365 |
D/D |
12,952 |
12,952 |
|
- |
|
| Patterson Matthew R |
Chief Executive Officer |
• • – |
2018-07-05 |
4 |
AS |
$40.04 |
$926,852 |
D/D |
(23,147) |
0 |
|
- |
|
| Patterson Matthew R |
Chief Executive Officer |
• • – |
2018-07-05 |
4 |
OE |
$0.78 |
$18,055 |
D/D |
23,147 |
23,147 |
|
- |
|
| Patterson Matthew R |
Chief Executive Officer |
• • – |
2018-07-03 |
4 |
AS |
$40.05 |
$1,077,460 |
D/D |
(26,901) |
0 |
|
- |
|
162 Records found
|
|
Page 3 of 7 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
